Consenso

← vista completa

Publicado el 1 de enero de 2009 | http://doi.org/10.5867/medwave.2010.01.4328

Revisión de la literatura sobre uso de resonancia magnética mamaria en cáncer de mama

Literature review on use of breast MRI in breast cancer

Paulina Neira, Patricia Arancibia, Bernardita Aguirre, Paulina González, Teresa Taub

Esta obra de Medwave está bajo una licencia Creative Commons Atribución-NoComercial 3.0 Unported. Esta licencia permite el uso, distribución y reproducción del artículo en cualquier medio, siempre y cuando se otorgue el crédito correspondiente al autor del artículo y al medio en que se publica, en este caso, Medwave.

Autores

Paulina Neira

Sociedad Chilena de Mastología

Patricia Arancibia

Sociedad Chilena de Mastología

Bernardita Aguirre

Sociedad Chilena de Mastología

Paulina González

Sociedad Chilena de Mastología

Teresa Taub

Sociedad Chilena de Mastología

Figures

Article has no figures.

Foro

No hay mensajes

Historial

Citación Neira P, Arancibia P, Aguirre B, González P, Taub T. Literature review on use of breast MRI in breast cancer. Medwave 2010;10(1):e4328 doi: 10.5867/medwave.2010.01.4328

Envío 29/07/2009

Aceptación 26/08/2009

Publicación 01/01/2010

Métricas del artículo

Artículo no tiene métricas.

Notas

Keywords

Resonancia magnética, quimioterapia neoadyuvante, cáncer de mama

Provenance and peer review

con revisión por pares externa

Referencias

  1. Bazzocchi M, Zuiani C, Panizza P, Del Frate C, Soldano F, Isola M, et al. Contrast-enhanced breast MRI in patients with suspicious microcalcifications on mammography: results of a multicenter trial. AJR Am J Roentgenol. 2006 Jun;186(6):1723-32. | CrossRef | PubMed
  2. Berg WA. Tailored supplemental screening for breast cancer: what now and what next? AJR Am J Roentgenol. 2009 Feb;192(2):390-9. | CrossRef | PubMed
  3. Braun M, Pölcher M, Schrading S, Zivanovic O, Kowalski T, Flucke U, et al. Influence of preoperative MRI on the surgical management of patients with operable breast cancer. Breast Cancer Res Treat. 2008 Sep;111(1):179-87. Epub 2007 Sep 29. | CrossRef | PubMed
  4. Chung A, Saouaf R, Scharre K, Phillips E. The impact of MRI on the treatment of DCIS. Am Surg. 2005 Sep;71(9):705-10. | PubMed
  5. Delille JP, Slanetz PJ, Yeh ED, Halpern EF, Kopans DB, Garrido L. Invasive ductal breast carcinoma response to neoadjuvant chemotherapy: noninvasive monitoring with functional MR imaging pilot study. Radiology. 2003 Jul;228(1):63-9. Epub 2003 May 29. | CrossRef | PubMed
  6. Deurloo EE, Klein Zeggelink WF, Teertstra HJ, Peterse JL, Rutgers EJ, Muller SH, et al. Contrast-enhanced MRI in breast cancer patients eligible for breast-conserving therapy: complementary value for subgroups of patients. Eur Radiol. 2006 Mar;16(3):692-701. Epub 2005 Nov 19. | CrossRef | PubMed
  7. Drew P, Turnbull L, Harvey I. MR imaging in breast cancer—Results of the COMICE trial (abstract 5). Eur J Surg Oncol. 2008;34:1156. | CrossRef
  8. El Khoury C, Servois V, Thibault F, Tardivon A, Ollivier L, Meunier M, et al. MR quantification of the washout changes in breast tumors under preoperative chemotherapy: feasibility and preliminary results. AJR Am J Roentgenol. 2005 May;184(5):1499-504. | PubMed
  9. Esserman LJ, Kumar AS, Herrera AF, Leung J, Au A, Chen YY, et al. Magnetic resonance imaging captures the biology of ductal carcinoma in situ. J Clin Oncol. 2006 Oct 1;24(28):4603-10. | CrossRef | PubMed
  10. Fischer U, Zachariae O, Baum F, von Heyden D, Funke M, Liersch T. The influence of preoperative MRI of the breasts on recurrence rate in patients with breast cancer. Eur Radiol. 2004 Oct;14(10):1725-31. Epub 2004 Jul 10. | CrossRef | PubMed
  11. Groves AM, Warren RM, Godward S, Rajan PS. Characterization of pure high-grade DCIS on magnetic resonance imaging using the evolving breast MR lexicon terminology: can it be differentiated from pure invasive disease? Magn Reson Imaging. 2005 Jul;23(6):733-8. | CrossRef | PubMed
  12. Houssami N, Ciatto S, Macaskill P, Lord SJ, Warren RM, Dixon JM, et al. Accuracy and surgical impact of magnetic resonance imaging in breast cancer staging: systematic review and meta-analysis in detection of multifocal and multicentric cancer. J Clin Oncol. 2008 Jul 1;26(19):3248-58. Epub 2008 May 12. | CrossRef | PubMed
  13. Hwang ES, Kinkel K, Esserman LJ, Lu Y, Weidner N, Hylton NM. Magnetic resonance imaging in patients diagnosed with ductal carcinoma-in-situ: value in the diagnosis of residual disease, occult invasion, and multicentricity. Ann Surg Oncol. 2003 May;10(4):381-8. | CrossRef | PubMed
  14. Hylton N. Dynamic contrast-enhanced magnetic resonance imaging as an imaging biomarker. J Clin Oncol. 2006 Jul 10;24(20):3293-8. | CrossRef | PubMed
  15. Hylton NM, Blume JD, Bernreuter WK, Pisano ED, Rosen MA, Morris EA, et al. Comparison of MRI endpoints for assessing breast cancer response to neoadjuvant treatment: preliminary findings of the American College of Radiology Imaging Network (ACRIN) trial 6657. | Link
  16. Ikeda O, Nishimura R, Miyayama H, Yasunaga T, Ozaki Y, Tsuji A, et al. Magnetic resonance evaluation of the presence of an extensive intraductal component in breast cancer. Acta Radiol. 2004 Nov;45(7):721-5. | CrossRef | PubMed
  17. Kneeshaw PJ, Lowry M, Manton D, Hubbard A, Drew PJ, Turnbull LW. Differentiation of benign from malignant breast disease associated with screening detected microcalcifications using dynamic contrast enhanced magnetic resonance imaging. Breast. 2006 Feb;15(1):29-38. Epub 2005 Jul 5. | CrossRef | PubMed
  18. Kuhl C. The current status of breast MR imaging. Part I. Choice of technique, image interpretation, diagnostic accuracy, and transfer to clinical practice. Radiology. 2007 Aug;244(2):356-78. | CrossRef | PubMed
  19. Kumar AS, Chen DF, Au A, Chen YY, Leung J, Garwood ER, et al. Biologic significance of false-positive magnetic resonance imaging enhancement in the setting of ductal carcinoma in situ. Am J Surg. 2006 Oct;192(4):520-4. | CrossRef | PubMed
  20. Kuroki Y, Nasu K. Advances in breast MRI: diffusion-weighted imaging of the breast. Breast Cancer. 2008;15(3):212-7. | CrossRef | PubMed
  21. Lehman CD, Gatsonis C, Kuhl CK, Hendrick RE, Pisano ED, Hanna L, et al. MRI evaluation of the contralateral breast in women with recently diagnosed breast cancer. N Engl J Med. 2007 Mar 29;356(13):1295-303. Epub 2007 Mar 28. | CrossRef | PubMed
  22. Li KL, Partridge SC, Joe BN, Gibbs JE, Lu Y, Esserman LJ, et al. Invasive breast cancer: predicting disease recurrence by using high-spatial-resolution signal enhancement ratio imaging. Radiology. 2008 Jul;248(1):79-87. | CrossRef | PubMed
  23. Londero V, Bazzocchi M, Del Frate C, Puglisi F, Di Loreto C, Francescutti G, et al. Locally advanced breast cancer: comparison of mammography, sonography and MR imaging in evaluation of residual disease in women receiving neoadjuvant chemotherapy. Eur Radiol. 2004 Aug;14(8):1371-9. Epub 2004 Feb 18. | CrossRef | PubMed
  24. Lord SJ, Lei W, Craft P, Cawson JN, Morris I, Walleser S, et al. A systematic review of the effectiveness of magnetic resonance imaging (MRI) as an addition to mammography and ultrasound in screening young women at high risk of breast cancer. Eur J Cancer. 2007 Sep;43(13):1905-17. Epub 2007 Aug 2. | CrossRef | PubMed
  25. Mann RM, Kuhl CK, Kinkel K, Boetes C. Breast MRI: guidelines from the European Society of Breast Imaging. Eur Radiol. 2008 Jul;18(7):1307-18. Epub 2008 Apr 4. | CrossRef | PubMed
  26. Menell JH, Morris EA, Dershaw DD, Abramson AF, Brogi E, Liberman L. Determination of the presence and extent of pure ductal carcinoma in situ by mammography and magnetic resonance imaging. Breast J. 2005 Nov-Dec;11(6):382-90. | PubMed
  27. Neira P, Aguirre B, Taub T, Gutiérrez L, Sáez C, Ibarra A, et al. Carcinoma ductal in situ: correlación entre la histología y la resonancia magnética de mama. Radiologia. 2009 Jul-Aug;51(4):396-402. Epub 2009 Apr 29. | CrossRef | PubMed
  28. Norman RP, Evans DG, Easton DF, Young KC. The cost-utility of magnetic resonance imaging for breast cancer in BRCA1 mutation carriers aged 30-49. Eur J Health Econ. 2007 Jun;8(2):137-44. Epub 2007 Mar 9. | CrossRef | PubMed
  29. Partridge SC, Gibbs JE, Lu Y, Esserman LJ, Sudilovsky D, Hylton NM. Accuracy of MR imaging for revealing residual breast cancer in patients who have undergone neoadjuvant chemotherapy. AJR Am J Roentgenol. 2002 Nov;179(5):1193-9. | PubMed
  30. Pengel KE, Loo CE, Teertstra HJ, Muller SH, Wesseling J, Peterse JL, et al. The impact of preoperative MRI on breast-conserving surgery of invasive cancer: a comparative cohort study. Breast Cancer Res Treat. 2009 Jul;116(1):161-9. Epub 2008 Sep 21. | CrossRef | PubMed
  31. Pickles MD, Manton DJ, Lowry M, Turnbull LW. Prognostic value of pre-treatment DCE-MRI parameters in predicting disease free and overall survival for breast cancer patients undergoing neoadjuvant chemotherapy. Eur J Radiol. 2009 Sep;71(3):498-505. Epub 2008 Jun 24. | CrossRef | PubMed
  32. Plevritis SK, Kurian AW, Sigal BM, Daniel BL, Ikeda DM, Stockdale FE, et al. Cost-effectiveness of screening BRCA1/2 mutation carriers with breast magnetic resonance imaging. JAMA. 2006 May 24;295(20):2374-84. | CrossRef | PubMed
  33. Rausch DR, Hendrick RE. How to optimize clinical breast MR imaging practices and techniques on Your 1.5-T system. Radiographics. 2006 Sep-Oct;26(5):1469-84. | CrossRef | PubMed
  34. Rieber A, Brambs HJ, Gabelmann A, Heilmann V, Kreienberg R, Kühn T. Breast MRI for monitoring response of primary breast cancer to neo-adjuvant chemotherapy. Eur Radiol. 2002 Jul;12(7):1711-9. Epub 2002 Feb 14. | CrossRef | PubMed
  35. Rosen EL, Blackwell KL, Baker JA, Soo MS, Bentley RC, Yu D, et al. Accuracy of MRI in the detection of residual breast cancer after neoadjuvant chemotherapy. AJR Am J Roentgenol. 2003 Nov;181(5):1275-82. | PubMed
  36. Sardanelli F, Giuseppetti GM, Panizza P, Bazzocchi M, Fausto A, Simonetti G, et al. Sensitivity of MRI versus mammography for detecting foci of multifocal, multicentric breast cancer in Fatty and dense breasts using the whole-breast pathologic examination as a gold standard. AJR Am J Roentgenol. 2004 Oct;183(4):1149-57. | PubMed
  37. Saslow D, Boetes C, Burke W, Harms S, Leach MO, Lehman CD, et al. American Cancer Society guidelines for breast screening with MRI as an adjunct to mammography. CA Cancer J Clin. 2007 Mar-Apr;57(2):75-89. | CrossRef | PubMed
  38. Schnall MD, Blume J, Bluemke DA, Deangelis GA, Debruhl N, Harms S, et al. MRI detection of distinct incidental cancer in women with primary breast cancer studied in IBMC 6883. J Surg Oncol. 2005 Oct 1;92(1):32-8. | CrossRef | PubMed
  39. Schrading S, Kuhl CK. Mammographic, US, and MR imaging phenotypes of familial breast cancer. Radiology. 2008 Jan;246(1):58-70. | PubMed
  40. Solin LJ, Orel SG, Hwang WT, Harris EE, Schnall MD. Relationship of breast magnetic resonance imaging to outcome after breast-conservation treatment with radiation for women with early-stage invasive breast carcinoma or ductal carcinoma in situ. J Clin Oncol. 2008 Jan 20;26(3):386-91. | CrossRef | PubMed
  41. Tardivon AA, Ollivier L, El Khoury C, Thibault F. Monitoring therapeutic efficacy in breast carcinomas. Eur Radiol. 2006 Nov;16(11):2549-58. Epub 2006 May 30. | CrossRef | PubMed
  42. Thibault F, Nos C, Meunier M, El Khoury C, Ollivier L, Sigal-Zafrani B, et al. MRI for surgical planning in patients with breast cancer who undergo preoperative chemotherapy. AJR Am J Roentgenol. 2004 Oct;183(4):1159-68. | PubMed
  43. Tillman GF, Orel SG, Schnall MD, Schultz DJ, Tan JE, Solin LJ. Effect of breast magnetic resonance imaging on the clinical management of women with early-stage breast carcinoma. J Clin Oncol. 2002 Aug 15;20(16):3413-23. | CrossRef | PubMed
  44. Van Goethem M, Schelfout K, Kersschot E, Colpaert C, Verslegers I, Biltjes I, et al. MR mammography is useful in the preoperative locoregional staging of breast carcinomas with extensive intraductal component. Eur J Radiol. 2007 May;62(2):273-82. Epub 2007 Jan 12. | CrossRef | PubMed
  45. Veltman J, Mann R, Kok T, Obdeijn IM, Hoogerbrugge N, Blickman JG, et al. Breast tumor characteristics of BRCA1 and BRCA2 gene mutation carriers on MRI. Eur Radiol. 2008 May;18(5):931-8. Epub 2008 Feb 13. | CrossRef | PubMed
  46. Warner E, Messersmith H, Causer P, Eisen A, Shumak R, Plewes D. Systematic review: using magnetic resonance imaging to screen women at high risk for breast cancer. Ann Intern Med. 2008 May 6;148(9):671-9. | PubMed
  47. Wasser K, Sinn HP, Fink C, Klein SK, Junkermann H, Lüdemann HP, et al. Accuracy of tumor size measurement in breast cancer using MRI is influenced by histological regression induced by neoadjuvant chemotherapy. Eur Radiol. 2003 Jun;13(6):1213-23. Epub 2002 Nov 30. | PubMed
  48. Yeh E, Slanetz P, Kopans DB, Rafferty E, Georgian-Smith D, Moy L, et al. Prospective comparison of mammography, sonography, and MRI in patients undergoing neoadjuvant chemotherapy for palpable breast cancer. AJR Am J Roentgenol. 2005 Mar;184(3):868-77. | PubMed